MindWalk Holdings (HYFT) Gross Margin (2020 - 2026)
MindWalk Holdings' (HYFT) quarterly Gross Margin came in at 60.63% in Q2 2026, down 326.0% year-over-year from 26.83% in Q2 2025, and up 2.32% quarter-over-quarter from 59.26% in Q1 2026.
Powered by 
Analysis
MindWalk Holdings (HYFT) Gross Margin (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Gross Margin for 7 consecutive years, with 60.63% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Gross Margin fell 326.0% year-over-year to 60.63% in Q2 2026; TTM through Apr 2026 was 58.78%, a 1785.0% increase from a year earlier, with the FY2026 full-year figure at 58.8%, up 487.0% from the prior year.
- Gross Margin was 60.63% for Q2 2026 at MindWalk Holdings, up from 59.26% in the prior quarter.
- Over five years, Gross Margin peaked at 73.98% in Q1 2022 and troughed at 40.84% in Q3 2024.
- A 5-year average of 56.95% and a median of 58.29% in 2023 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin sank 1666 bps in 2023 and surged 1345 bps in 2025, its largest moves.
- Over 5 years, Gross Margin stood at 53.61% in 2022, then declined by 10 bps to 48.03% in 2023, then gained by 6 bps to 51.1% in 2024, then advanced by 26 bps to 64.55% in 2025, then declined by 6 bps to 60.63% in 2026.
- The last three Gross Margin figures came in at 60.63% (Q2 2026), 59.26% (Q1 2026), and 64.55% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 32.85% |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 28.51% |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 45.02% |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 23.23% |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 20.52% |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | 91.47% |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | 50.78% |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | 60.63% |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 60.63% |
| Jan 31, 2026 | 59.26% |
| Oct 31, 2025 | 64.55% |
| Jul 31, 2025 | 48.31% |
| Apr 30, 2025 | 63.89% |
| Jan 31, 2025 | 64.55% |
| Oct 31, 2024 | 51.10% |
| Jul 31, 2024 | 40.84% |
| Apr 30, 2024 | 62.38% |
| Jan 31, 2024 | 51.39% |
| Oct 31, 2023 | 48.03% |
| Jul 31, 2023 | 49.14% |
| Apr 30, 2023 | 59.44% |
| Jan 31, 2023 | 57.32% |
| Oct 31, 2022 | 53.61% |
| Jul 31, 2022 | 53.44% |
| Apr 30, 2022 | 63.29% |
| Jan 31, 2022 | 73.98% |
| Oct 31, 2021 | 58.65% |
| Jul 31, 2021 | 54.61% |